One of the downsides to getting older is that skeletal muscle loses its ability to heal after injury. New research from the University of Pittsburgh implicates the so-called “longevity protein” Klotho, both as culprit and therapeutic target.
The paper, published this week in Nature Communications, showed that, in young animals, Klotho expression soars after a muscle injury, whereas in old animals, it remains flat. By raising Klotho levels in old animals, or by mitigating downstream effects of Klotho deficiency, the researchers could restore muscle regeneration after injury.
“We found that we were able to rescue, at least in part, the regenerative defect of aged skeletal muscle,” said lead author Fabrisia Ambrosio, Ph.D., director of rehabilitation for UPMC International, associate professor of physical medicine and rehabilitation at Pitt, and core faculty at the McGowan Institute of Regenerative Medicine. “We saw functional levels of muscle regeneration in old animals that paralleled those of their young counterparts, suggesting that this could potentially be a therapeutic option down the road.”
Suspecting that Klotho acts through mitochondria dysfunction, the researchers gave Klotho-deficient animals a mitochondria-targeting drug called SS-31, which currently is in phase III clinical trials. Treated animals grew more new muscle tissue at the site of injury compared to untreated controls, and their strength after recovery rivaled that of genetically normal mice.
Similarly, injecting Klotho into older animals a few days after injury resulted in greater muscle mass and better functional recovery than their saline-treated counterparts. Normal, healthy mice did not benefit from SS-31 after injury.
Clinically, these findings could translate to older adults who either sustained a muscle injury or underwent muscle-damaging surgery. Giving them Klotho at the appropriate timepoint could boost their muscle regeneration and lead to a more complete recovery.
Ambrosio cautions that the timing, dosage and route of administration will require future research.
“If you just bombard the muscle with Klotho, we do not expect to observe any functional benefit,” Ambrosio said. “We’ve found that mimicking the timing profile we see in young animals seems to be critical. We think that this gives some insight into the therapeutic window.”
The Latest on: Klotho
via Google News
The Latest on: Klotho
- Dr. Banny S. Wongon March 23, 2020 at 5:00 pm
Dr. Banny S. Wong is a gastroenterologist in Vancouver, Washington and is affiliated with multiple hospitals in the area, including Legacy Salmon Creek Medical Center and PeaceHealth Southwest ...
- Dr. Peter A. Abdelmalikon March 23, 2020 at 5:00 pm
Dr. Peter A. Abdelmalik is a neurologist in Buffalo, New York and is affiliated with Buffalo General Medical Center. He received his medical degree from St. George's University School of Medicine ...
- American journal of translational researchon March 17, 2020 at 5:00 pm
Resibufogenin inhibits ovarian clear cell carcinoma (OCCC) growth in vivo, and migration of OCCC cells in vitro, by down-regulating the PI3K/AKT and actin cytoskeleton signaling pathways.
- Aging clinical and experimental researchon March 10, 2020 at 5:00 pm
Resveratrol and 1,25-dihydroxyvitamin D co-administration protects the heart against D-galactose-induced aging in rats: evaluation of serum and cardiac levels of klotho. Strength training is ...
- The kinetics of inorganic phosphate excretion in the acidotic rabbit during intravenous phosphate loading: a pseudo-ruminant modelon March 4, 2020 at 2:18 am
The rabbit (Oryctolagus cuniculus) has an organ called the caecum that functions in a similar fashion to that of the rumen in a cow. However, unlike ruminants, this fermentation vessel in the rabbit ...
- Can fasting improve your memory?on January 17, 2020 at 10:00 am
Each participant also had a blood test to measure levels of a protein called Klotho, which normally declines with age. Several studies have established that an increase in Klotho is a marker of ...
- NGM.O - NGM Biopharmaceuticals Inc Profile | Reuterson October 25, 2019 at 11:13 am
NGM313 is an agonistic antibody selectively activating fibroblast growth factor receptor 1c-beta-klotho and has the potential as an insulin sensitizer for the treatment of type two diabetes and NASH.
- Secret of longevity protein revealed!on January 18, 2018 at 11:54 am
Washington D.C. , Jan. 17 : A team of researchers has discovered an anti-ageing protein, named after a Greek goddess, which may play an important role in the treatment of multiple diseases ranging ...
- Chronic Stress Can Shorten Your Lifespanon June 18, 2015 at 9:46 am
It's more than just cortisol levels—a new study links lower levels of the hormone klotho to reduced longevity among women Scientists from the University of California, San Francisco, have discovered a ...
via Bing News